Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Opens Proteomics Lab With Australia's Monash University in Malaysia

NEW YORK (GenomeWeb) – Agilent Technologies has announced a partnership with Monash University Malaysia to open a jointly-run laboratory for proteomics, metabolomics, and multi-omics research.

Under the terms of the agreement, Agilent will provide hardware, software, staff training, and technical support for the Integrative Biology Laboratory, which will feature Agilent's iFunnel technology and a 6550 quadrupole time-of-flight liquid chromatograph/mass spectrometer. Agilent will also provide the Australian university's Malaysian campus with early access to new microarray technology and will collaborate with the school to design arrays for its screening and research projects.

"With the Agilent mass spectrometer at its heart, this laboratory will help strengthen our current proteomics, metabolomics and small-molecules research capabilities," Monash Malaysia Professor Dato' Anuar Zaini said in a statement.

The new laboratory expands the partnership between Agilent and Monash, which created a microarray laboratory at the Malaysian campus in 2011. The new lab, which will be housed at the university's Jeffrey Cheah School of Medicine and Health Sciences outside Kuala Lumpur, will conduct workshops and training for local and international scientists.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.